Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
What Are The Best Penny Stocks To Buy If You Like Biotech? 3 To Watch
-
Legacy Acquisition (LGC) and Onyx Enterprises Int’l Corp. Announce Business Combination
-
Legacy Acquisition Corp. and Onyx Enterprises Int’l Corp. Announce Business Combination
-
GCM Grosvenor Reports Strong Second Quarter Fiscal 2020 Results, Continued Positive Trends in July and August. Management expects to outperform prior full year 2020 forecast.
-
XL Fleet to List on NYSE Through Merger With Pivotal Investment Corporation II (PIC)
-
XL Fleet, a Commercial Vehicle Electrification Solutions Leader, to List on NYSE Through Merger With Pivotal Investment Corporation II
-
Metalla Royalty & Streaming Ltd. (MTA:CN) (MTA) PT Raised to Cdn$11.25 at Cantor Fitzgerald, Following Mining Update
-
Orchid Island Capital Announces September 2020 Monthly Dividend and August 31, 2020 RMBS Portfolio Characteristics
-
ACE Convergence Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Redeemable Warrants Commencing September 17, 2020
-
Form 424B3 Cantor Fitzgerald Income
-
Cantor Fitzgerald Defends Nano-X Imaging (NNOX) Following Short Report
-
Arcutis to Present at the Cantor Fitzgerald Global Healthcare Conference 2020
-
Merck to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
-
Charlotte\'s Web Holdings (CWEB:CN) (CWBHF) PT Lowered to $3.90 at Cantor Fitzgerald
-
Merck (MRK), Seattle Genetics (SGEN) announce new collaborations and investment, analysts see positives in them
-
Bellerophon to Present at Two September Investor Conferences
-
Charity Day Virtual & Unstoppable For BGC Partners & Cantor Fitzgerald
-
Cantor Fitzgerald & BGC Partners' Charity Day 2020 Virtually Unstoppable
-
Lilly to Participate in Cantor Fitzgerald Virtual Global Healthcare Conference
-
Ovid Therapeutics to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
-
Mirum Pharmaceuticals to Present at Investor Conferences in September
-
KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference
-
Spero Therapeutics (SPRO) Announces Pricing of Common Stock and Series D Convertible Preferred Stock
-
Spero Therapeutics Announces Pricing of Securities Offering
-
Spero Therapeutics Announces Pricing of Securities Offering
-
Trump, Biden take break from campaign to commemorate 9/11 anniversary
-
Intra-Cellular Therapies (ITCI) Prices 11.67M Share Common Offering at $30/Sh
-
Intra-Cellular Therapies Prices Public Offering of Common Stock
-
Stealth BioTherapeutics to Present at Upcoming Investor Conferences in September
-
AcelRx Pharmaceuticals to Present at Two Upcoming Conferences
-
Curis to Present at Upcoming Investor Conferences
-
McEwen Mining Announces Closing of Financing
-
McEwen Mining Announces Closing of Financing
-
SIGA to Participate at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 17, 2020
-
DURECT Corporation to Participate in September Virtual Investor Conferences
-
Chimerix to Participate in Upcoming Investor Conferences
-
Gossamer Bio Announces Participation in Upcoming Investor Conferences
-
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences
-
ESSA Pharma to Participate in Multiple Upcoming Investor Conferences
-
Spero Therapeutics (SPRO) Announces Proposed 8M Share Common Offering
-
Spero Therapeutics Announces Proposed Public Offering
-
Spero Therapeutics Announces Proposed Public Offering
-
HighCape Capital Acquisition Corp. Announces Closing of $115 Million Initial Public Offering
-
Xencor to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
-
Pipeline Therapeutics to Present at Two Upcoming Investor Conferences
-
Makor Group Hires New Vice President For Middle East Operations, Daniel Nevo
-
TG Therapeutics to Present at Upcoming Investor Conferences
-
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
-
Veru to Participate and Present at Four Upcoming Healthcare Investor Conferences
-
VYNE Therapeutics (formerly Menlo Therapeutics) to Present at the Cantor Fitzgerald and H.C. Wainwright Investment Conferences in September

